Volatile organic compounds as potential biomarkers for the diagnosis of digestive diseases. A review
Open Access
- 5 August 2024
- journal article
- review article
- Published by Consilium Medicum in Consilium Medicum
- Vol. 26 (5) , 303-308
Abstract
Diseases of the digestive system are very common among the population around the world. Diagnosis of the diseases of this group is expensive and often invasive, which greatly limits its accessibility to the population. Increasing the time of disease development before diagnosis increases the risk of complications and adverse outcomes. The use of volatile organic compounds (VOC) as a biomarker is becoming increasingly popular due to the accuracy and ease of use. The article examines the available analytical platforms of VOCs for detecting changes in the state of the digestive system, assesses their strengths and weaknesses, provides examples of VOC assessment tool for the diagnosis of certain diseases of the digestive system – inflammatory bowel diseases, colorectal cancer, infectious diarrhea and celiac disease.Keywords
This publication has 62 references indexed in Scilit:
- A novel non-invasive colorectal cancer diagnostic method: Volatile organic compounds as biomarkersClinica Chimica Acta, 2023
- Quartz crystal microbalance-based biosensors as rapid diagnostic devices for infectious diseasesBiosensors and Bioelectronics, 2020
- Release of volatile organic compounds (VOCs) from colorectal cancer cell line LS174TAnalytical Biochemistry, 2019
- Colorectal cancer and adenoma screening using urinary volatile organic compound (VOC) detection: early results from a single-centre bowel screening population (UK BCSP)Techniques in Coloproctology, 2019
- PTR-MS and GC-MS as complementary techniques for analysis of volatiles: A tutorial reviewAnalytica Chimica Acta, 2018
- Gut microbiota in the pathogenesis of inflammatory bowel diseaseClinical Journal of Gastroenterology, 2017
- The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemiaCancer, 2016
- Application of gas chromatography mass spectrometry (GC–MS) in conjunction with multivariate classification for the diagnosis of gastrointestinal diseasesMetabolomics, 2014
- Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle studyInternational Journal of Cancer, 2013
- Progress in SIFT‐MS: Breath analysis and other applicationsMass Spectrometry Reviews, 2011